The global Hypoparathyroidism Treatment Market was
valued at USD 1.25 billion in 2023 and is projected to
reach USD 2.25 billion by 2032, growing at a compound annual growth
rate (CAGR) of 6.8% over the forecast period from 2024
to 2032. The increasing prevalence of hypoparathyroidism, along with
advancements in targeted therapies and growing awareness of treatment options,
is expected to drive significant market growth.
Market Overview
Hypoparathyroidism is a rare endocrine disorder cha...
more